Algert Global LLC Sells 12,070 Shares of Option Care Health, Inc. $OPCH

Key Points

• Algert Global LLC reduced its holdings in Option Care Health, Inc. by 4.9%, owning 236,072 shares worth approximately $8.25 million after selling 12,070 shares in the first quarter.
• Institutional investors now own 98.05% of Option Care Health's stock, with notable increases from Wells Fargo and Sterling Capital Management in recent quarters.
• Analysts have raised their target prices for Option Care Health, with UBS upgrading the stock to a "buy" rating and setting a target price of $40.

Algert Global LLC decreased its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 4.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 236,072 shares of the company's stock after selling 12,070 shares during the quarter. Algert Global LLC owned 0.14% of Option Care Health worth $8,251,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Nuveen LLC bought a new position in Option Care Health during the first quarter valued at about $70,965,000. Allspring Global Investments Holdings LLC boosted its stake in Option Care Health by 6,525,926.1% during the first quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock valued at $52,459,000 after buying an additional 1,500,963 shares in the last quarter. Voloridge Investment Management LLC bought a new position in Option Care Health during the fourth quarter valued at about $27,428,000. Freestone Grove Partners LP bought a new position in Option Care Health during the fourth quarter valued at about $17,487,000. Finally, Boston Partners bought a new position in Option Care Health during the first quarter valued at about $24,353,000. Institutional investors own 98.05% of the company's stock.

Wall Street Analyst Weigh In

OPCH has been the subject of several research reports. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. JMP Securities raised their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, Barrington Research reiterated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research report on Thursday, July 10th. Eight investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $35.75.

Option Care Health Stock Up 3.2%

Option Care Health stock traded up $0.90 during mid-day trading on Friday, hitting $28.74. The company's stock had a trading volume of 2,369,675 shares, compared to its average volume of 1,937,741. The firm's 50 day moving average is $29.92 and its 200 day moving average is $31.75. The company has a market cap of $4.66 billion, a PE ratio of 22.99, a price-to-earnings-growth ratio of 1.76 and a beta of 0.79. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business's revenue for the quarter was up 15.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Activity

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of Option Care Health stock in a transaction that occurred on Wednesday, August 20th. The stock was purchased at an average cost of $27.15 per share, with a total value of $977,400.00. Following the purchase, the director owned 375,390 shares in the company, valued at approximately $10,191,838.50. The trade was a 10.61% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Timothy P. Sullivan acquired 20,000 shares of Option Care Health stock in a transaction that occurred on Thursday, August 21st. The stock was acquired at an average cost of $27.51 per share, with a total value of $550,200.00. Following the completion of the purchase, the director owned 49,229 shares in the company, valued at approximately $1,354,289.79. This represents a 68.43% increase in their position. The disclosure for this purchase can be found here. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.